Item request has been placed!
×
Item request cannot be made.
×
Processing Request
Single nucleotide polymorphism rs3124599 in Notch1 is associated with the risk of lung cancer in northeast Chinese non-smoking females.
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
- Additional Information
- Source:
Publisher: Impact Journals Country of Publication: United States NLM ID: 101532965 Publication Model: Print Cited Medium: Internet ISSN: 1949-2553 (Electronic) Linking ISSN: 19492553 NLM ISO Abbreviation: Oncotarget Subsets: MEDLINE
- Publication Information:
Original Publication: Albany, N.Y. : Impact Journals
- Subject Terms:
- Abstract:
Lung cancer is one of the most common cancers and the main cause of cancer-related deaths. Notch1 might play a part in tumorigenesis of lung cancer. Here we explored the relationship of three SNPs (rs3124599, rs3124607 and rs3124594) in Notch1 with the risk and the survival of lung cancer in non-smoking females, including 556 cases and 395 controls. Chi-square tests, logistic regression analysis and crossover analysis were conducted to estimate the association between SNPs and the risk of lung cancer and the interaction between SNPs and environmental exposure. Survival analysis was conducted to explore the association between SNPs and survival of lung cancer. The results demonstrated that the polymorphism of rs3124599 was associated with the susceptibility of lung cancer in recessive model (AA+AG vs. GG). Compared to the those with AA or AG genotype, individuals with GG genotype had a 1.562-fold increased risk of lung cancer (P = 0.023, OR = 1.562, 95% CI = 1.062-2.297). In stratified analysis, the GG genotype of rs3124599 would increase the risk of small cell lung cancer (SCLC) (P = 0.011, OR = 2.167, 95% CI = 1.193-3.396). However, no significant interaction between rs3124599 and cooking oil fume exposure was observed either in addictive model or multiplicative model. The results of survival analysis showed there was no significant association between SNPs and prognosis of lung cancer (P = 0.949 for rs3124599, P = 0.508 for rs3124607, P = 0.884 for rs3124594). Our study might indicate that rs312599 in Notch1 may be a novel biomarker for SCLC risk in Chinese non-smoking females.
- References:
Genes Chromosomes Cancer. 2014 Aug;53(8):657-66. (PMID: 24729385)
Proc Natl Acad Sci U S A. 2009 Dec 29;106(52):22293-8. (PMID: 20007775)
BMC Med Genet. 2015 Apr 10;16:22. (PMID: 25928368)
Clin Cancer Res. 2015 Mar 1;21(5):955-61. (PMID: 25388163)
Lung Cancer. 2014 Aug;85(2):131-40. (PMID: 24888228)
Med Oncol. 2016 Apr;33(4):35. (PMID: 26971121)
Biochem Biophys Res Commun. 2006 Jul 14;345(4):1460-5. (PMID: 16729972)
PLoS Genet. 2010 May 13;6(5):e1000952. (PMID: 20485568)
Biochem Biophys Res Commun. 2011 May 20;408(4):589-94. (PMID: 21530495)
Science. 2004 Oct 8;306(5694):269-71. (PMID: 15472075)
Cancer Res. 2001 Apr 1;61(7):3200-5. (PMID: 11306509)
Dis Markers. 2010;28(6):353-60. (PMID: 20683149)
J Hematol Oncol. 2015 Feb 06;8:9. (PMID: 25653136)
Nat Rev Cancer. 2009 Sep;9(9):655-64. (PMID: 19693096)
Curr Biol. 2000 May 4;10(9):491-500. (PMID: 10801437)
Cell Mol Life Sci. 2007 Nov;64(21):2746-62. (PMID: 17687513)
Int J Clin Exp Pathol. 2014 Jun 15;7(7):4286-94. (PMID: 25120811)
Am J Transl Res. 2015 Jan 15;7(1):162-74. (PMID: 25755838)
Lung Cancer. 2014 Dec;86(3):304-10. (PMID: 25456735)
CA Cancer J Clin. 2015 Mar;65(2):87-108. (PMID: 25651787)
EMBO J. 2001 Jul 2;20(13):3427-36. (PMID: 11432830)
Genome Res. 2012 Sep;22(9):1790-7. (PMID: 22955989)
Sci Rep. 2016 Apr 01;6:24014. (PMID: 27035284)
BMC Cancer. 2009 Dec 15;9:439. (PMID: 20003463)
J Exp Med. 2011 Sep 26;208(10):1931-5. (PMID: 21948802)
Nature. 2010 Apr 1;464(7289):773-7. (PMID: 20220756)
Nucleic Acids Res. 2008 Jan;36(Database issue):D820-4. (PMID: 17986460)
Thorac Cancer. 2016 Jan;7(1):123-8. (PMID: 26816546)
- Contributed Indexing:
Keywords: Notch1; lung cancer; non-smoking females; single nucleotide polymorphisms; small cell lung cancer
- Accession Number:
0 (NOTCH1 protein, human)
0 (Receptor, Notch1)
- Publication Date:
Date Created: 20170419 Date Completed: 20180326 Latest Revision: 20221207
- Publication Date:
20240829
- Accession Number:
PMC5458199
- Accession Number:
10.18632/oncotarget.16101
- Accession Number:
28415716
No Comments.